Synthetic cannabinoids

• Prenatal cannabinoid exposure: why expecting individuals should take a pregnancy pause from using cannabinoid products (02 Sep 2024)
  
• Potential perioperative cardiovascular outcomes in cannabis/cannabinoid users. A call for caution (02 Sep 2024)
  
• Activity-based detection of synthetic cannabinoid receptor agonists in plant materials (02 Sep 2024)
  
• Targeting Cannabinoid Receptors: Current Status and Prospects of Natural Products (20 Aug 2024)
  
• The Modulating Role of Sex and Anabolic-Androgenic Steroid Hormones in Cannabinoid Sensitivity (19 Aug 2024)
  
• Clinical characteristics of synthetic cannabinoid-induced psychosis in relation to schizophrenia: a single-center cross-sectional analysis of concurrently hospitalized patients (18 Aug 2024)
  
• Case Series of Synthetic Cannabinoid Intoxication from One Toxicology Center (18 Aug 2024)
  
• First-Episode of Synthetic Cannabinoid-Induced Psychosis in a Young Adult, Successfully Managed with Hospitalization and Risperidone (12 Aug 2024)
  
• Exploring the topic structure and abuse trends of new psychoactive Substance since the 21st century from a bibliometric perspective (24 May 2024)
  
• An emerging trend in Novel Psychoactive Substances (NPSs): designer THC (24 May 2024)
  
• The systems medicine of cannabinoids in pediatrics: the case for more pediatric studies (27 Aug 2022)
  
• The use and effects of synthetic cannabinoid receptor agonists by New South Wales cannabis treatment clients - Journal of Cannabis Research (26 Jul 2022)